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Abstract
Background: The prevalence of asthma and allergic diseases has increased in industrialised countries, and
it is known that rates vary according whether the area is urban or rural and to socio-economic status.
Surveys conducted in some urban settings in Latin America found high prevalence rates, only exceeded by
the rates observed in industrialised English-speaking countries. It is likely that the marked changes in the
environment, life style and living conditions in Latin America are responsible for these observations. The
understanding of the epidemiological and immunological changes that underlie the increase in asthma and
allergic diseases in Latin America aimed by SCAALA studies in Brazil and Ecuador will be crucial for the
identification of novel preventive interventions.
Methods/Design: The Salvador-SCAALA project described here is a longitudinal study involving children
aged 4–11 years living in the city of Salvador, Northeastern Brazil. Data on asthma and allergic diseases
(rhinitis and eczema) and potential risk factors will be collected in successive surveys using standardised
questionnaire. This will be completed with data on dust collection (to dust mite and endotoxin), skin test
to most common allergens, stool examinations to helminth and parasites, blood samples (to infection, total
and specific IgE, and immunological makers), formaldehyde, physical inspection to diagnoses of eczema, and
anthropometric measures. Data on earlier exposures when these children were 0–3 years old are available
from a different project.
Discussion: It is expected that knowledge generated may help identify public health interventions that
may enable countries in LA to enjoy the benefits of a "modern" lifestyle while avoiding – or minimising –
increases in morbidity caused by asthma and allergies.
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Background
The prevalence of asthma and allergic diseases (rhinitis
and eczema) has increased in industrialised countries in
the last 2 decades [1-3]; in the same countries, there is ten-
dency for the prevalence to be higher in urban than rural
areas and to vary according to socio-economic status,
although these findings are not consistent in all studies.
Allergic disease results from a complex interaction
between host genetics and environmental exposures [4]
Since changes in host genetics occurring over so short a
time scale is an unlikely explanation for the temporal
trends in allergy prevalence, it is likely that the marked
changes in environmental, life style and living conditions
are known to have occurred in the last decades are respon-
sible for these differences. Changes suggested t have con-
tributed include urbanisation, better housing, diet and
decreased exposure to infection early in life, and less expo-
sures to helminths and other chronic infections.
Among environmental exposures that may have contrib-
uted to the trends in allergy prevalence, those that have
attracted most interest are the fall in exposures to infec-
tious diseases. The so-called "hygiene hypothesis" pro-
posed that increases in the prevalence of allergic diseases
were explained by improvements in living conditions, use
of antibiotics and childhood vaccinations leading to a
reduction in exposure to infections in early life [5]. Differ-
ent immunological mechanisms have been postulated to
mediate the biologic effects underlying the hygiene
hypothesis. It has been hypothesised that exposure to viral
and bacterial infections [5,6] and some vaccines [6-8] in
early life, can enhance type-1 (Th1) immunity and the
production of cytokines (i.e. IFN-g) that inhibit directly
allergy-promoting type-2 (Th2) immune responses. The
observation that individuals exposed to type-2 (Th2)-pro-
moting helminth infections have a reduced prevalence of
allergic disease has led to a reworking of this biological
model. The new model hypothesises that early infectious
diseases provide important regulatory signals for the
establishment of robust immune regulation in early life,
thereby preventing the development of the deregulated
immunity associated with allergy.
Whatever the mechanisms involved the strong evidence
that the temporal allergy trends are related to changes in
lifestyle and living conditions raises the possibility that
preventive interventions against allergic diseases can be
identified. The understanding of the epidemiological and
immunological changes that underlie the increase in
asthma and allergic diseases will be crucial for the identi-
fication of novel preventive interventions.
International studies of the asthma prevalence have been
conducted with the International Study of Asthma and
Allergies in Childhood (ISAAC) study group using a
standardised written questionnaire for self-reported
asthma and respiratory symptoms. In these surveys, some
Latin American settings (Brazil, Peru, Costa Rica, Paraguay
and Uruguay) had very high prevalence rates, that were
exceeded only by industrialised English-speaking coun-
tries [7]. These results appear inconsistent with the
"hygiene hypothesis", given the poor socio-economic
conditions and environmental problems present in most
regions of Latin America (LA). LA countries suffer enor-
mous societal disparities in wealth and development and
with a large proportion of the population living in poverty
[8,9]. It is not clear, therefore, why LA appears to have
such high a prevalence of asthma, and there is scarce avail-
able information on how asthma and allergic diseases in
LA vary according to socio-economic, urban-rural, envi-
ronmental and life-styles factors. Studies in Brazil have
shown that the prevalence of asthma is higher among
non-white children and in those from low-income fami-
lies [10,11].
The study described here is part of a larger ongoing
research programme being conducted in Brazil (in the
Northeastern city of Salvador) and Ecuador. Populations
in both countries have experienced recent changes in liv-
ing conditions and life style (urbanisation, improvement
in sanitation). This research programme is funded by The
Wellcome Trust through the programme of Major Awards
to Centres of Excellence in Latin America and has adopted
the name SCAALA (Social Changes, Asthma and Allergy in
Latin America Programme). This paper specifically deals
with the methodological aspects of the cohort study being
conducted in Salvador, Brazil.
The Salvador cohort study has two main objectives.
Firstly, to investigate the associations between the preva-
lence of asthma and other allergic diseases (rhinitis,
atopic eczema) and potential risk factors that includes liv-
ing conditions and early life and current exposures to
infections, and secondly, to investigate how the associa-
tion between environment factors, allergic diseases and
markers of atopy (i.e. skin-prick test and total and specific
serum IgE levels) are mediated by serum interleukins. In
contrast, the study in Ecuador aims to study frequency of
atopy and allergic diseases and exposure to potential risk
factor in rural populations and in migrants from rural to
urban areas; and examine how these may explain the risk
of atopic diseases in migrants from rural to urban areas.
This study will be described in a separate paper.
Methods/Design
Study site
Salvador, the capital of the State of Bahia, in the Northeast
Brazil has approximately 2.5 million inhabitants, and is
located in the poorest region in the country. Over 80% of
the population is black or mixed-race (mulatto). There is
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a high degree of social inequality: GINI coefficient was
0.66 in 2000 [12]. The city currently presents high cover-
age of childhood vaccination (essentially 100% for neo-
natal BCG and measles-mumps-rubella vaccine, in 2003),
water supply (95% of households with water supply in
2000) and sanitation (75% households with sanitation
connection in 2000). The city of Salvador has several
advantages as the site for this study. First, a ISAAC survey
conducted in 1995 demonstrated a high prevalence of
asthma: 27.1% and 12.5% of schoolchildren aged 13–14
years reported wheezing in the last 12 months [13] and
asthma ever, respectively. Another study showed a preva-
lence of 10% among schoolchildren aged 12–16 years
[14]. Second, significant improvements in living condi-
tions have occurred in recent years. A sanitation pro-
gramme was recently implemented (increasing the
households connected to a safe sewage disposal from 30%
to 70%) with subsequent reduction in the prevalence of
intestinal parasitic infection and incidence of childhood
diarrhoea [15]. Third, the health impact of such a sanita-
tion programme has been assessed by a large epidemio-
logic study[15]; the participants of the evaluation of
impact of the sanitation programme were recruited as the
study population of the present study on allergic diseases.
Study population and sampling
Children in this research project have been part of a study
conducted earlier to evaluate the impact of the sanitation
programme on the occurrence of childhood diarrhoea.
This first study was originally designed to enrol three sep-
arate cohorts of children aged 0–3 years recruited from 24
small geographical areas selected to represent the popula-
tion without sanitation in Salvador, called sentinel-areas
[16,17] These three cohorts were recruited in 1997, 2001
and 2003, respectively. Within each selected area, a survey
was conducted at baseline and the cohort was then fol-
lowed up. Sampling and data collection procedures and
instruments were the same in the 3 surveys and follow up
making the study populations comparable. In each sur-
vey, children were randomly selected among those living
in each area. Standardised questionnaires were applied
during the baseline surveys to obtain data on demo-
graphic characteristics and living conditions of the fami-
lies, sanitation, water supply and other characteristics of
the households, pre-natal care, weight-at-birth, breast-
feeding, attendance to kindergarten and vaccination sta-
tus of children, nutritional status (anthropometry),
characteristics of the neighbourhood and indoor environ-
ment. Children were then followed-up regularly for a
period of one year from recruitment, forming thus the 3
cohort populations. During follow-up, children were vis-
ited every 2 weeks and data on occurrence of diarrhoea,
cough, shortness of breath and fever as reported by the
guardian was collected. Weight and height were measured
using standard techniques and z-scores for height-for-age,
weight-for-age and weight-for-height were calculated. A
stool sample was collected and examined for parasitic
infections. Details of the methodology and results of the
first survey and cohort study have been published else-
where [18-20].
To take advantage of these three cohorts (since detailed
information for them had been collected on early life fac-
tors proposed as potential risk factors for asthma and
other allergic diseases), the children who were aged 4–11
years and had complete follow-up information (e.g. stool
examination conducted at 3 different time points) were
selected for the present study.
Study design
Follow-up during the current study on asthma and allergic
diseases consists of two additional surveys to be con-
ducted between 2005 and 2006, and again in 2008. The
two surveys will assess children from the three previous
cohort studies and will: (i) update information collected
in the baseline surveys (ii) collect information on addi-
tional risk factors, (iii) collect stool samples for diagnosis
of intestinal parasitic infections, (iv) collect blood sam-
ples for immunological analysis, (v) collect dust to meas-
ure allergen exposure, (vi) collect data on formaldehyde
and particulate levels indoors and outdoors and (vii) col-
lect data on asthma and allergic diseases (rhinitis, atopic
eczema). The information collected during previous sur-
veys and follow-up will be used in the present study to
investigate early risk factors relating to infectious disease
exposures and living conditions of the children from
birth. All children from the previous 3 cohort studies were
eligible to enter the present study.
Sample size and study power
The total number of children recruited in the first resurvey
with questionnaires completed was 1,445. Given this total
number of children recruited, the magnitude of the prev-
alence rate ratio to be estimated with at least 80% of study
power and 95% precision for selected characteristics were
calculated by comparing proportions in STATA (com-
mand "sampsi"). This was done assuming an estimate of
asthma prevalence of 10% [14], significance level of 5%,
and the proportion of children exposed to specific risk fac-
tors, considering a loss rate of 10% and without making
allowance for possible effect of clustering. Results for 4
selected characteristics are shown in Table 1.
Main outcomes and case definition
Asthma, rhinitis and eczema will be defined according to
the International Study of Allergy and Asthma in Child-
hood (ISAAC) [7]. Atopy will be defined as either a posi-
tive allergen skin prick test or the presence of allergen-
specific IgE and allergy as the presence of clinical condi-
tion (asthma, rhinitis or eczema) in the presence of atopy
BMC Pulmonary Medicine 2006, 6:15 http://www.biomedcentral.com/1471-2466/6/15
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[21]. Because no information on atopy or allergic diseases
was collected previously, the frequency of allergic diseases
will be measured as prevalence rates in the survey in 2005,
and prevalence and incidence rates in the second survey in
2008 (incidence among those without disease in 2005);
atopy will be estimated as prevalence in 2005 and rate of
conversion/reversion in 2008.
Data collection and instruments
The field work of the surveys in 2005 and 2008 involves 7
different activities, each conducted by different field
teams and supervised by at least one of the co-investiga-
tors. Application of the main questionnaire, anthropo-
metric survey, and stool and dust sample collection were
completed in 2005. The activities were:
1. Questionnaire: mostly based on the ISAAC Phase II
questionnaire [7], translated into Brazilian Portuguese.
Some additional questions were included on environ-
ment, housing conditions, allergic diseases and potential
risk factors, as described below. Questionnaire applica-
tion was done by trained field workers, after piloting the
questionnaire in children outside the study population
but in the same target age. Medical assistance by the
project in a referral outpatient care unit and by project
doctors will be offered for all study children identified as
having severe asthma.
2. An anthropometric survey with two independent meas-
ures of height and weight collected in a standardised way
conducted by trained nutritionists, taking the mean value
as the final measure, as recommended by WHO: z-scores
for weight-for-age, weight-for-height and height-for-age
were calculated using the EPINUT program (Epi Info 6.0;
CDC, Atlanta, GA, USA) (details published elsewhere
[20]).
3. Stool samples collected for helminths and parasites
with two different samples for each child, 2 days apart.
Stools were analysed using the gravitational sedimenta-
tion technique of Hoffman, Pons & Janner to detect
helminth eggs, protozoan cysts and oocysts. Two slides
were examined for each stool sample. Quantification of
helminth eggs was performed using the Kato-Katz tech-
nique [22]. All children with positive results were treated
with appropriate antiparasitic drugs (Albendazole and
Tinidazole).
4. Dust samples collected using a residential vacuum
cleaner (Eletrolux Professional, 1220 watts) containing a
nylon 25 um micromesh sock filter [23]. The childrens'
beds were aspirated for two minutes over a 1 m2 area,
adjacent to the head side. The filters were weighed before
and after collection of the dust samples. Fibres and large
particles were removed from the dust with forceps and the
fine particulated dust samples were weighed, aliquotted as
100 mg samples and cryo-preserved at -20°C. Tempera-
ture and air humidity were recorded at the bedroom with
a thermohygrometer (Minipa Ind & Co, São Paulo, Bra-
zil).
Table 1: Estimation of the sample size and power of the study
Assuming study power of 80%
Risk factors (all categorical values: 
1 = exposed, 0 = not exposed)
Number of children with 
data on the risk factor
Proportion exposed 
(risk factor = 1)
Estimated number 
with asthma
Estimated prevalence in: PRR4
n 90% not exposed exposed
(a) (b) (c)1 (d) (e)2 (f) (g) (i)
Measles vaccination 
(unvaccinated over vaccinated)
1,407 1,266 0.75 126 0.083 0.15 1.7
Maternal smoking during 
pregnancy (smoker over non-
smoker)
1,412 1,271 0.14 127 0.09 0.17 1.9
Sanitation connection 1,409 1,268 0.52 127 0.07 0.13 1.7
Maternal schooling (illiterate 
and primary over higher 
schooling)
1,441 1,296 0.76 130 0.05 0.11 2.0
1-assuming a loss rate of 10% for the survey in 2005, it is (b) multiplied by 0.9;
2-assuming a asthma prevalence of 10%, it is (c) multiplied by 0.1;
3- unvaccinated;
4- prevalence rate ratio.
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5. Blood samples: An aliquot of 10 mL collected to meas-
ure (i) total and allergen specific IgE (anti-mite, and anti-
cockroach), (ii) IgG antibodies to Hepatitis A virus, Her-
pes simplex, Herpes zoster, and Epstein-Barr viruses, A.
lumbricoides, T. trichura, Toxoplasma gondii and Toxocara
canis, and (iii) cytokines IFN-gamma, IL-13 and IL-10 and
TGF-β in supernatant fluids collected from antigen-stimu-
lated whole blood cultures.
6. Skin prick test (SPT) carried out by allergen skin prick
testing of the right forearm of each children using extracts
(ALK-Abello, São Paulo, Brazil) of Dermatophagoides ptero-
nyssinus, Blomia tropicalis, Blattella germanica, Periplaneta
americana, fungi, dog and cat epithelia. Saline and hista-
mine was used as negative and positive controls, respec-
tively. Wheal sizes will be read after 15 minutes and
reactions will be considered positive if the mean of the
two larger perpendicular diameters of the reaction is at
least three millimeters superior to the mean of the two
larger perpendicular diameters of the negative control
reaction area.
7. Skin inspection for flexural dermatitis performed by
trained observers using the ISAAC phase II protocol [24]
will complement data on atopic eczema collected by ques-
tionnaire.
Laboratory techniques
Aeroallergens will be quantified from dust samples by
capture ELISA using commercially available kits (Indoor
Biotechnologies, Virginia, USA) for the following aeroal-
lergens: Blomia tropicalis Blo t 5, Dermatophagoides ptero-
nyssinus Der p 1, Blatella germanica Bla g 2, Cat Fel d1,
Dog Can f1Bacterial endotoxin and fungal b-glucan will
be measured using the Limulus Amebocyte Lysate (LAL)
assay (Cambrex Bio-Ciência do Brasil Ltda) following the
manufacturers' instructions.
Heparinised whole blood will be cultivated at a dilution
at 1:4 in RPMI (Gibco, Auckland, NZ) containing 10 mM
glutamine (Sigma, St. Louis, MO, USA), 100 μg/ml of gen-
tamicyn (Sigma, St. Louis, MO, USA), and stimulated with
the following antigens: Ascaris lumbricoides (10 μg/ml);
Blomia tropicalis (40 μg/ml); Dermatophagoides pteronyssi-
nus (5 μg/ml). Pookweed mitogen (Gibco, Auckland, NZ)
diluted at 1/1000 will be used as a positive control and
media alone as negative control. House dust mites culti-
vated in fish food will be purified, lysed in pH 7.4 phos-
phate saline (PBS) with the use of a blender (Blender
51BL30; Waring Commercial, Torrington, Connecticut,
U.S.A.). The A. lumbricoides antigen will be obtained by
trituration of liquid nitrogen frozen adult worms
obtained from a child treated with albendazole, in a
blender as stated above in the presence of PBS. After cen-
trifugation, the supernatants will be cryopreserved for
storage before use. All antigens will be depleted of endo-
toxin by treatment with triton-114 (Sigma, St. Louis, MO,
USA) and the protein contents will be determined by the
Lowry method. Whole blood cultures will be cultivated at
5% CO2, for 24 hours for detection of IL-10 and for 5 days
for the detection of IL-13, TGF-β and IFN-gamma.
Cytokines in supernatant fluids will be measured using
Pharmigen BD antibody pairs and recombinant standards
(Pharmigen, San Diego, Ca, USA) by capture ELISA fol-
lowing the manufacturer's instructions. Cytokines will be
estimated by interpolation of standard curves of recom-
binant standards.
Total IgE will be measured as follows: COSTAR high bind-
ing microassay plates (COSTAR, Cambridge, Me, U.S.A.)
will be coated with 4 μg/ml of an anti- human -IgE anti-
body (PHARMIGEM, San Diego, CA, USA) overnight at
4C. Plates will be blocked with 0.15 M phosphate-buff-
ered saline, pH 7.2 (PBS), containing 20% of dried
skimmed milk (DSM) and 0.05% of Tween 20 (Sigma, St
Louis, MO, USA) overnight, at 4°C. Sera to be tested and
IgE antibody standards (RESEARCH DIAGNOSTICS INC,
Flanders, NJ, USA). will be diluted 1:10 in PBS containing
10% of DSM and 0.05% of Tween 20 and incubated over-
night at 4°C. A goat anti-human IgE-peroxidase conjugate
(SIGMA, St Louis, MO, USA), and an anti-goat immu-
noglobulin-peroxidase conjugate (DAKO A/S, Glostrup,
Denmark), will be diluted at 1:2000 and 1:10.000, respec-
tively, and incubated for 60 minutes at room temperature.
The results will be expressed in International Units (IU).
A pool of parasite infected patients' sera will be used as
positive control. Umbilical cord serum from a non-atopic
and non-parasited mother will be used as negative con-
trol.
Determination of specific IgE serum concentration will be
done for Dermatophagoides pteronyssinus, Blomia tropicalis,
Blatella germanica, dog and cat epithelia main allergens
using the RAST system (Pharmacia Diagnostics AB, Upsala
Sweden).
Detection of anti-parasite antibodies. Anti-A. lumbricoides
IgG4 will be detected by an indirect ELISA using wells of
high binding microassay plates (COSTAR, Cambridge,
Me, U.S.A.), sensitized with 20 μg/ml, of the parasite anti-
gen as stated above, diluted in carbonate-bicarbonate pH
9,6 buffer. The sera will be diluted at 1:50 in PBS contain-
ing 10% skimmed milk and 0,1 % tween 20 (PBS/SM/T).
The reaction will be detected using a biotinylated anti-
human-IgG4/(SIGMA Chemical Co., San Louis, MO,
USA), streptoavidin/peroxidase (PHARMIGEN., San Jose,
CA, EUA) and H2O2 e OPD (MERCK & Co., Inc., White
house Station, NJ, USA). The assay cut-off will be the
mean plus 3 SD of negative controls (sera from people
with 3 negative stool samples collected serially). Anti-Tox-
BMC Pulmonary Medicine 2006, 6:15 http://www.biomedcentral.com/1471-2466/6/15
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ocara IgG antibodies will be detected using 20 μg/ml of
larvae excretorial-secretorial antigen obtained by cultiva-
tion of the larva as described by De Savigny et al. [30] (The
sera will be diluted at 1:100 in PBS/SM/T and pre-
absorbed with A. lumbricoides; the development of the
reaction will be done as described for A. lumbricoides IgG4
except for the conjugate that will be a biotinylated anti-
human IgG. The assay cut of will be the mean plus 3 SD
of negative controls (sera from upper middle class people,
without history of dog and cat contact). Anti-Toxoplama
gondii IgG and IgM will be detected using commercially
available ELISA kits (Diamedix Corporation, Miami,
USA), following the manufacturer's instructions. IgG anti-
body against the following virus will measured: Herpes
simplex, Herpes zoster, Epstein-Bahr and Hepatitis A
virus. Detection will be done using commercially availa-
ble ELISA kits (Diamedix Corporation, Miami, USA), fol-
lowing the manufacturers' instructions.
Main risk factors
Data for study variables were collected either (i) during
the 3 previous baseline surveys and that will be updated
in the 2 forthcoming surveys (2005 and 2008), or (ii) are
new data to be collected in these 2 forthcoming surveys.
Table 2 shows the data to be collected and the timing of
data collection.
In the earlier cohorts no data was collected regarding
asthma and hence incidence cannot be estimated in the
first survey (2005). In the second survey (2008) a measure
of incidence will be estimated reflecting new cases arising
between 2005 and 2008. However, establishing asthma
diagnosis in infancy is difficult. Additional information
on occurrence of episodes of shortness of breath, fever
and cough that are available for a year following the base-
line surveys will also be used. This information may be
more accurate than prevalence estimates estimated from
data collected using a later questionnaire for asthma
symptoms in infancy.
Overview of plan of analysis
Statistical analysis will be conducted according to a con-
ceptual framework defining a proposed causal pathway.
Bivariate association analysis will be carried out by calcu-
lating prevalence ratios and 95% confidence intervals to
measure the strength of the association between each
potential risk factor and the outcomes of interest. At his
stage, the main outcomes of interest are atopy (expressed
as skin test positivity and level of IgE to allergen), asthma
and allergy). Multivariate analysis will be taken out in sev-
eral steps. First, within each level, multivariate data reduc-
tion techniques (e.g. principal component analysis) will
be applied to summarise highly correlated variables to
index variables (e.g. socio economic status, Th1- related
immune response). Secondly, for each level, multivariate
regression models will be fitted to estimate association
parameters adjusted for confounding factors of the same
level. In addition, multi-level modelling and robust vari-
ance estimation techniques will be used to adjust for
intra-subject correlation due to repeated measures on the
same individual and/or geographical areas. Finally, to
address the complex inter-relationships between risk fac-
tors of different levels and outcomes according to our pre-
defined conceptual framework, we will apply the follow-
ing analysis strategies: i) A hierarchical effect decomposi-
tion strategy fitting a sequence of regression models each
including different blocks of covariates, similar to an
approach suggested by other authors [25]; ii) Log-linear
models, an association analysis technique for multi
dimensional contingency tables to estimate conditional
association parameters (relative risks), conditional on the
distribution of the risk factors on the higher levels [26,27].
For example, the probability of developing asthma will be
estimated, conditional on a positive skin prick test, a high
IgE level and environmental exposures. In addition, inter-
action parameters will be introduced to model how the
risk factors on different levels influence each other (e.g.
modelling the impact of environmental exposures on the
effect of high IgE level); iii) Finally, sophisticated statisti-
cal techniques such as structural equation modelling and
path analysis [28,29] will be used to model the multiple
relationships defined in the conceptual framework simul-
taneously aimed to quantify direct and mediated effect
components of the risk factors [30].
Ethical considerations
Ethical approval was obtained from the Brazilian
National Ethical Committee in 2004. Written informed
consent was obtained from the legal guardian of each sub-
ject. It details all the procedures in the course of the
project. All the clinical relevant results will be sent to the
subjects parents, and specific recommendations will be
done by a trained clinician after reviewing each case.
Discussion
The SCAALA programme that includes the Salvador and
the Ecuador project, is expected to provide important new
information and contribute to our understanding of why
the prevalence of asthma and allergies appear to be so
high in urban settings in LA. The two studies have differ-
ent objectives and designs, but they have similar concep-
tual frameworks and share expertise and operational
resources. These projects require extensive co-ordination,
involve expertise from several different disciplines (epide-
miology, medicine, immunology, chemistry, nutrition,
social sciences) and complex logistics (large-scale field
work, laboratory work, standardisation of instruments
and techniques, data base set up and linkage and
advanced analysis). Study designs used include surveys
and case-control studies making possible the comparison
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Table 2: Variables already collected and variables to be collected in the current survey
Study variables Origin of the data
Previous baseline surveys and follow-up Present survey 2005–20061
Demographic and socio-economic
Sex X
Birth date X X
Race/skin color X
On socio-economic condition:
• parental schooling X X
• domestic goods X X
Environmental factors
Sanitation and water supply X X
Presence of pets X
Indoor smoking X
Housing (e.g., floor, number of rooms) X X
Presence of allergens in dust (mites and cockroach) X
Presence of endotoxin and mould in the house X
Whether the house is located in an area of intense car traffic X
Psycho-social factors
domestic violence X
Experience of discrimination X
Resilience X
Maternal and family related factors
Maternal smoking during pregnancy X X
Asthma and other allergic diseases in the family X
Number of pregnancies X X
Child health
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Prenatal Care X X
Weight at birth X
Breast-feeding duration X X
Vaccination (BCG, DTP, measles) X X
Whether attended kindergarten X X
Number of people who live in each household X
Nutritional status X X
Global health status, as evaluated by the guardian X
Diarrhoea longitudinal prevalence X
Cough longitudinal prevalence X
Short of breath longitudinal prevalence X
Fever longitudinal prevalence X
Other infections (pneumonia, otites, causes for hospitalisations) X X
Use of antibiotics X X
Specific Infections
Intestinal helminth and parasitic infections (stool examinations) X X
Serologic test to A. lumbricoides, T. trichura, Toxopalsma. gondii, Toxocara canis, hepatitis A and 
other virus
X
Atopy
Skin prick test X
Total and specific IgE titres to most important allergens X
Antibody to mites and cockroach X
Immunological makers
IL-10, IL-13, TGF-β, IFN-Gamma X
Note: the same data are planned to be collected in a survey scheduled to 2008.
Table 2: Variables already collected and variables to be collected in the current survey (Continued)
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of prevalence and risk factors for asthma and other allergic
diseases between urban and rural environments (the
Ecuador study) and a longitudinal study of the effects of
early life exposures of an urban population on asthma
and other allergic diseases (the Salvador study). The labo-
ratory component will explore the relative importance of
different immunological mechanisms in mediating the
effects of environment exposures (with emphasis on
helminths and other infectious diseases of childhood) on
the risk of asthma and allergic diseases. Statistical analysis
will involve the use of strategies that link data from differ-
ent levels (e.g. socio-economic, environmental, clinical
and immunological factors) and will use advanced statis-
tical techniques to deal with this complex framework
The Salvador study is the continuation of three different
cohorts initiated several years ago with objective of study-
ing the effects in changes in sanitation on the risk of infec-
tious diseases The earlier data collected for these cohort
studies, therefore, will provide important information
that will allow the study to examine the importance of the
'hygiene hypothesis' in determining allergy risk in an poor
urban centre of LA Theses cohorts provide prospective
data over a period of 12 months from between birth and
3 years of age. Data was collected through home visits
every 2 on diarrhoea, reported fever, cough and shortness
of breath. Demographic, socio-economic, sanitation-
related environmental data was collected also. Each child
was weighed, height was measured, and a stool sample
was collected for parasitologic assessment. Second,
although data was collected at the individual level, the use
of "sentinel areas" throughout Salvador made possible the
collection of community level aggregate data and or cen-
sus data
In summary, the proposed programme aims to clarify the
social and biological mechanisms mediating the effect of
population changes on the frequency of atopic disease in
LA. Latin America is undergoing a rapid process of popu-
lation change, including urbanization, migration, eco-
nomic development and adoption of a "modern" lifestyle.
Efforts to improve water supply, sanitation, rubbish col-
lection and other hygienic measures are common to the
different LA countries. It is expected that knowledge gen-
erated may thus help identify public health interventions
that may enable countries In LA to enjoy the benefits of a
"modern" lifestyle while avoiding – or minimising –
increases in morbidity caused by asthma and allergies.
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